Efficacy and safety of casirivimab-imdevimab combination on COVID-19 patients: A systematic review and meta-analysis randomized controlled trial

Wicaksono, Imam Adi; Suhandi, Cecep; Elamin, Khaled M.; Wathoni, Nasrul

doi:10.1016/j.heliyon.2023.e22839

Heliyon

2023

DOI: 10.1016/j.heliyon.2023.e22839

|View full text |Cite

Efficacy and safety of casirivimab-imdevimab combination on COVID-19 patients: A systematic review and meta-analysis randomized controlled trial

Imam Adi Wicaksono,

Cecep Suhandi,

Khaled M. Elamin

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial

Kjellberg,

Douglas,

Pawlik

et al. 2024

Respiratory Medicine

View full text Add to dashboard Cite

Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial

Kjellberg,

Douglas,

Pawlik

et al. 2024

Respiratory Medicine

View full text Add to dashboard Cite

Comparing the Effectiveness and Safety of Casirivimab/Imdevimab With Bamlanivimab in Patients With Covid-19: A Systematic Review and Meta-Analysis

Karimi Babaahmadi,

Mohajeri Iravani,

Orandi

et al. 2024

Studies in Medical Sciences

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Efficacy and safety of casirivimab-imdevimab combination on COVID-19 patients: A systematic review and meta-analysis randomized controlled trial

Cited by 2 publications

References 36 publications

Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial

Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial

Comparing the Effectiveness and Safety of Casirivimab/Imdevimab With Bamlanivimab in Patients With Covid-19: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About